Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy

被引:15
|
作者
Owens, Emily [1 ]
Krecke, Karl [2 ]
Ahlskog, J. E. [1 ]
Fealey, Robert [1 ]
Hassan, Anhar [1 ]
Josephs, Keith A. [1 ]
Klassen, Bryan [1 ]
Matsumoto, Joseph [1 ]
Bower, James [1 ]
机构
[1] Mayo Clin, Dept Neurol, 200 Second St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Neuroradiol, 200 Second St SW, Rochester, MN 55905 USA
关键词
Progressive supranuclear palsy; Imaging; MRI; MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; ROUTINE MRI; PONS RATIO; MIDBRAIN; DIFFERENTIATION; VARIANT; INDEX;
D O I
10.1016/j.parkreldis.2016.05.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The diagnosis of progressive supranuclear palsy is often challenging early in the course of the disease, when clinical signs of the condition may be less apparent and patients do not clearly meet diagnostic criteria. In this study, we examine a potential radiographic marker in progressive supranuclear palsy, and assess the timing of its presence in relation to diagnosis. Methods: A retrospective review of patients fulfilling clinical research criteria for multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy (total n = 75) was performed. Midbrain and pontine diameters, and the midbrain to pons ratio were calculated by a neuroradiologist blinded to the clinical diagnosis. The timing of the presence of a midbrain to pons ratio of less than or equal to 0.52 was assessed in the progressive supranuclear palsy group in reference to the time of diagnosis. Results: The midbrain to pons ratio was significantly reduced in the progressive supranuclear palsy cohort (p < 0.0001), and a midbrain to pons ratio of less than or equal to 0.52 was 100% specific for progressive supranuclear palsy. This radiologic sign predated the clinical diagnosis of progressive supranuclear palsy by a mean of 15 months (range 1-47 months) in 14 of 17 (82%) of patients in whom it was found. Conclusions: The midbrain to pons ratio is an easily applied and highly specific tool in the diagnosis of progressive supranuclear palsy, and is frequently present before the diagnosis is made. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 50 条
  • [31] Progressive supranuclear palsy: clinical and genetic aspects
    Pastor, P
    Tolosa, E
    CURRENT OPINION IN NEUROLOGY, 2002, 15 (04) : 429 - 437
  • [32] Clinical pain and experimental pain sensitivity in progressive supranuclear palsy
    Stamelou, Maria
    Dohmann, Helena
    Brebermann, Juliane
    Boura, Evangelia
    Oertel, Wolfgang H.
    Hoeglinger, Gunter
    Moeller, Jens C.
    Mylius, Veit
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (05) : 606 - 608
  • [33] Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy
    Grijalva, Rosalie M.
    Pham, Nha Trang Thu
    Huang, Qiao
    Martin, Peter R.
    Ali, Farwa
    Clark, Heather M.
    Duffy, Joseph R.
    Utianski, Rene L.
    Botha, Hugo
    Machulda, Mary M.
    Weigand, Stephen D.
    Ahlskog, J. Eric
    Dickson, Dennis W.
    Josephs, Keith A.
    Whitwell, Jennifer L.
    MOVEMENT DISORDERS, 2022, 37 (04) : 702 - 712
  • [34] Longitudinal clinical decline and baseline predictors in progressive supranuclear palsy
    Pavone, Costanza
    Weigand, Stephen W.
    Ali, Farwa
    Clark, Heather M.
    Botha, Hugo
    Machulda, Mary M.
    Savica, Rodolfo
    Pham, Nha Trang Thu
    Grijalva, Rosalie M.
    Schwarz, Christopher G.
    Senjem, Matthew L.
    Agosta, Federica
    Filippi, Massimo
    Jack, Clifford R.
    Lowe, Val J.
    Josephs, Keith A.
    Whitwell, Jennifer L.
    PARKINSONISM & RELATED DISORDERS, 2023, 107
  • [35] Clinical outcomes of progressive supranuclear palsy and multiple system atrophy
    O'Sullivan, S. S.
    Massey, L. A.
    Williams, D. R.
    Silveira-Moriyama, L.
    Kempster, P. A.
    Holton, J. L.
    Revesz, T.
    Lees, A. J.
    BRAIN, 2008, 131 : 1362 - 1372
  • [36] Differentiation of Progressive Supranuclear Palsy: clinical, imaging and laboratory tools
    Liscic, R. M.
    Srulijes, K.
    Groeger, A.
    Maetzler, W.
    Berg, D.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 127 (05): : 362 - 370
  • [37] Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy
    Surova, Yulia
    Nilsson, Markus
    Latt, Jimmy
    Lampinen, Bjorn
    Lindberg, Olof
    Hall, Sara
    Widner, Hakan
    Nilsson, Christer
    van Westen, Danielle
    Hansson, Oskar
    NEURORADIOLOGY, 2015, 57 (11) : 1079 - 1091
  • [38] MDS criteria for the diagnosis of progressive supranuclear palsy overemphasize Richardson syndrome
    Frank, Anika
    Peikert, Kevin
    Linn, Jennifer
    Brandt, Moritz D.
    Hermann, Andreas
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (09): : 1702 - 1707
  • [39] Retinal Thinning as a Marker of Disease Severity in Progressive Supranuclear Palsy
    Chen, Yueting
    Wang, Haotian
    Wang, Bo
    Li, Wenbo
    Ye, Panpan
    Xu, Wen
    Liu, Peng
    Chen, Xinhui
    Cen, Zhidong
    Ouyang, Zhiyuan
    Wu, Sheng
    Dou, Xiaofeng
    Liao, Yi
    Zhang, Hong
    Tian, Mei
    Luo, Wei
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (01) : 55 - 63
  • [40] Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
    Wiblin, Louise
    Durcan, Rory
    Galna, Brook
    Lee, Mark
    Burn, David
    JOURNAL OF MOVEMENT DISORDERS, 2019, 12 (03) : 177 - 183